Meropenem/Nacubactam (OP0595/ RG6080)

Drug combination: beta-lactam (carbapenem) + beta-lactamase inhibitor (diazabicyclooctane)
Meiji Seika Pharma Co. Ltd./Fedora Pharmaceuticals Inc. (Roche licensee)